Form 4: Sabra Health Care REIT Executive Acquires Shares Through Dividend Equivalents
SEC Form 4 Filing
Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, acquired 2,429 shares of common stock through dividend equivalent payments.
Summary
- Michael Lourenco Costa, an executive at Sabra Health Care REIT, acquired 2,429 shares of common stock.
- These shares were obtained through dividend equivalent payments on previously granted stock units.
- The transaction occurred on November 29, 2024.
- The acquired shares are part of the company's 2009 Performance Incentive Plan.
- Mr. Costa also disposed of 784 shares held indirectly through his IRA.
- Additionally, he holds 207 shares indirectly through his spouse's IRA.
- Mr. Costa's total holdings include 154,070 stock units that will be settled one-for-one in common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively. The acquisition of shares through dividend equivalents is a positive sign of alignment with shareholder interests.
Positives
- The acquisition of shares through dividend equivalents indicates a continued alignment of executive interests with shareholder value.
- The stock units will vest and become payable on the same terms as the original stock units to which they relate.
Negatives
- The disposal of 784 shares through Mr. Costa's IRA could be seen as a slight reduction in his overall holdings, although this is a small amount compared to his total holdings.
Risks
- There are no specific risks mentioned in this document.
Industry Context
This is a routine filing related to executive compensation and is common in the REIT industry. It reflects standard practices for aligning executive interests with shareholder value through equity-based compensation.
Comparison to Industry Standards
- Executive compensation through stock options and dividend equivalents is a common practice in the REIT industry.
- Many REITs use similar performance incentive plans to align executive interests with shareholder value.
- The number of shares acquired is not unusual for an executive at this level.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the stock acquisition and disposal. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Sabra Health Care REIT, Michael Lourenco Costa, stock acquisition, dividend equivalents, executive compensation, insider trading, Form 4, stock units, performance incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.